Seres Therapeutics Inc (NAS:MCRB) Stock News, Headlines & Updates
Seres Therapeutics Inc Stock News from GuruFocus
- 1
Jul 22, 2025
Seres Therapeutics to Announce Second Quarter 2025 Financial Results and Business Updates on August 6, 2025
Marketwired • 7:00am
Seres Therapeutics (MCRB) Announces Transition in Executive Leadership | MCRB Stock News
GuruFocus News • 6:35am
Seres Therapeutics to Announce Second Quarter 2025 Financial Results and Business Updates on August 6, 2025 | MCRB Stock News
GuruFocus News • 6:19am
Seres Therapeutics Announces Leadership Transition | MCRB Stock News
GuruFocus News • 6:17am
Seres Therapeutics Announces Leadership Transition
Marketwired • 6:00am
Jun 13, 2025
FMR LLC Reduces Stake in Seres Therapeutics Inc: A Strategic Reassessment?
GuruFocus News • 7:34pm
May 27, 2025
Seres Therapeutics (MCRB) to Present New Biomarker Data at ASCO 2025 | MCRB Stock News
GuruFocus News • 6:45am
Seres Therapeutics Presents Expanded SER-155 Exploratory Biomarker Data at 2025 ASCO Annual Meeting
Marketwired • 6:00am
May 08, 2025
MCRB: Seres Therapeutics' Price Target Raised by Chardan Capital | MCRB Stock News
GuruFocus News • 6:35am
Q1 2025 Seres Therapeutics Inc Earnings Call Transcript
GuruFocus News • 11:10pm
May 07, 2025
Seres Therapeutics (MCRB) Targets Advancement of SER-155 in Clinical Development | MCRB Stock News
GuruFocus News • 6:21am
Seres Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Updates
Marketwired • 6:00am
Apr 29, 2025
Seres Therapeutics (MCRB) to Unveil New Findings at 2025 Digestive Disease Week | MCRB Stock News
GuruFocus News • 6:47am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news